UnitedHealth Group cut its guidance after reporting a surge in care activity in its Medicare Advantage businesses last quarter.
UnitedHealth Group Inc (NYSE:UNH) will announce its first-quarter report before the open tomorrow, April 17.
CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now?
Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Get a deeper insight into the potential performance of UnitedHealth (UNH) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
UNH's first-quarter earnings are likely to have benefited from growing premiums and service revenues.
UnitedHealth (UNH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The CMS announced a hike in MA payments for fiscal year 2026, which will likely deliver a notable boost to UNH & HUM's bottom lines.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The Investment Committee give you their top stocks to watch for the second half.
UnitedHealth Group continues to deliver sector-crushing dividend growth to its shareholders. The company's revenue and adjusted diluted EPS climbed higher in the fourth quarter. UnitedHealth Group maintains strong financials.